Internal Medicine, Gastroenterology · Philadelphia, PA
NPI
1275571945
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
11400 Bustleton Ave
Philadelphia, PA, 19116
Phone (215) 969-8446
Groups this clinician bills Medicare through
Medicare paid, 2024
$268K
3,334 services
Medicare patients, 2024
945
Average age 78
Drug cost, 2024
$2.2M
7,851 prescriptions
Company payments, 2025
$6,047
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Oleg Volchonok was code 99213 (office e&m - established), 815 times for 447 patients. In total Oleg Volchonok billed 3,334 services in 33 codes, and Medicare paid $268K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 815 | 447 | $79.62 | $65K |
| 99214 Office E&M - Established | Office | 347 | 280 | $111.25 | $39K |
| 99211 Office E&M - Established | Office | 319 | 213 | $20.46 | $6,526 |
| 99442 Telephone Services | Office | 272 | 186 | $79.44 | $22K |
| 99212 Office E&M - Established | Facility | 263 | 232 | $30.31 | $7,972 |
| 99232 Hospital E&M - Subsequent | Facility | 238 | 163 | $68.48 | $16K |
| 43239 Upper GI Endoscopy | Facility | 192 | 187 | $117.50 | $23K |
| 88305 Surgical Pathology Examination | Office | 111 | 37 | $30.96 | $3,437 |
| 99233 Hospital E&M - Subsequent | Facility | 108 | 106 | $101.27 | $11K |
| 99222 Hospital E&M - Initial | Facility | 96 | 95 | $112.72 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 88 | 88 | $136.23 | $12K |
| 99443 Telephone Services | Office | 78 | 67 | $111.88 | $8,727 |
| 99223 Hospital E&M - Initial | Facility | 65 | 64 | $150.51 | $9,783 |
| 88342 Immunohistochemistry | Office | 52 | 27 | $28.36 | $1,475 |
| 99203 Office E&M - New | Office | 51 | 51 | $96.27 | $4,910 |
By year: 2022 $228K for 2,994 services; 2023 $260K for 3,459 services; 2024 $268K for 3,334 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 111 | 37 | $30.96 | $3,437 |
| 88342 Immunohistochemistry | 52 | 27 | $28.36 | $1,475 |
| 88312 Surgical Pathology Examination | 28 | 25 | $21.83 | $611 |
| 88313 Surgical Pathology Examination | 28 | 26 | $10.24 | $287 |
Medicare prescription drug claims, 2024
In 2024, the drug Oleg Volchonok prescribed most often to Medicare patients was Pantoprazole Sodium, with 2,214 prescriptions and refills. In total Oleg Volchonok wrote 7,851 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 2,214 | 2,821 | 421 | $17K |
| Famotidine Generic | 1,050 | 1,189 | 179 | $5,760 |
| Linzess Linaclotide | 1,032 | 1,091 | 174 | $578K |
| Metoclopramide Hcl Generic | 460 | 475 | 121 | $3,213 |
| Omeprazole Generic | 448 | 556 | 113 | $2,881 |
| Creon Lipase/Protease/Amylase | 446 | 473 | 71 | $413K |
| Dexlansoprazole Dr Dexlansoprazole | 335 | 387 | 46 | $72K |
| Procto-Med Hc Hydrocortisone | 273 | 275 | 88 | $2,521 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 153 | 153 | 144 | $24K |
| Dicyclomine Hcl Generic | 131 | 136 | 40 | $1,838 |
| Proctozone-Hc Hydrocortisone | 130 | 130 | 51 | $1,216 |
| Zenpep Lipase/Protease/Amylase | 118 | 131 | 23 | $124K |
| Esomeprazole Magnesium Generic | 84 | 115 | 20 | $4,247 |
| Mirtazapine Generic | 74 | 86 | 22 | $476 |
| Dexilant Dexlansoprazole | 57 | 57 | Under 11 | $17K |
Brand drugs: 2,130 claims; generic drugs: 5,721 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Oleg Volchonok $6,047 ($6,047 in general payments such as food, travel and fees) from 16 companies. The largest payer was Phathom Pharmaceuticals, Inc. with $3,740.
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. PHAT | 7 | $3,740 |
| Gilead Sciences, Inc. GILD | 16 | $505 |
| Ardelyx, Inc. ARDX | 12 | $326 |
| Aimmune Therapeutics, Inc. | 5 | $222 |
| Abbvie Inc. ABBV | 15 | $220 |
| QOL Medical, LLC | 9 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 11 | $183 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $132 |
| Janssen Biotech, Inc. JNJ | 5 | $125 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.